About Her2 Positive Breast Cancer Drug Perjeta ( Pertuzumab )

http://youtu.be/BwVPPNa6MAA Perjeta (pertuzumab) is a breast cancer drug showing promise extending the lives of people with an aggressive type of breast cancer referred to as HER2-positive breast cancer. Visit http://www.canceris.net/perjeta-her2-positive-breast-cancer-treatment/to learn more about this promising new cancer treatment. Given intravenously, as part of a combination with cancer drugs Herceptin and Taxotere, the drug may be used in the neoadjuvant treatment, where chemotherapy is given to the patient before surgery, as well as during the initial treatment of metastatic cancer, where the cancer has spread beyond the breast to other areas.